Journal of Clinical Microbiology, April 2001, p. 1211-1216, Vol. 39, No. 4
Department of Pathology, University Hospital
Vrije Universiteit, 1081 HV Amsterdam, The Netherlands
Received 6 September 2000/Returned for modification 13 December
2000/Accepted 15 January 2001
Epstein-Barr virus (EBV) DNA load monitoring in peripheral blood
has been shown to be a useful tool for the diagnosis of aberrant EBV
infections. In the present study we compared the relative diagnostic
values of EBV DNA load monitoring in unfractionated whole blood and
simultaneously obtained serum or plasma samples from Burkitt's
lymphoma (BL) patients, transplant recipients, human immunodeficiency
virus (HIV)-infected individuals, and infectious mononucleosis (IM)
patients by a quantitative competitive PCR (Q-PCR). The EBV DNA load in
BL patients was mainly situated in the cellular blood compartment (up
to 4.5 × 106 copies/ml). EBV DNA loads in
unfractionated whole blood and parallel serum samples showed no
correlation. In transplant recipients, IM patients, and HIV-infected
patients, the EBV burden in the circulation was almost exclusively
restricted to the cellular blood compartment, because serum or plasma
samples from these patients yielded negative results by Q-PCR, despite
high viral loads in corresponding whole-blood samples. A 10-fold more
sensitive but qualitative BamHI-W-repeat PCR occasionally
revealed the presence of EBV at <2,000 copies of EBV DNA per ml of
serum. Spiking of 100 copies of EBV DNA in samples with negative Q-PCR
results excluded the presence of inhibitory factors in serum or plasma
that influenced the Q-PCR result. Serum samples from all populations
were often positive for
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.4.1211-1216.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Toward Standardization of Epstein-Barr Virus DNA Load Monitoring:
Unfractionated Whole Blood as Preferred Clinical Specimen
-globin DNA, indicating cell damage in vivo
or during serum preparation. We conclude that serum is an undesirable
clinical specimen for EBV DNA load monitoring because it omits the
presence of cell-associated virus and uncontrolled cell lysis may give irreproducible results or overestimation of the DNA load.
Unfractionated whole blood is strongly preferred since it combines all
blood compartments that may harbor EBV and it best reflects the
absolute viral burden in the patient's circulation.
*
Corresponding author. Mailing address: Department of
Pathology, University Hospital Vrije Universiteit, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Phone: 31-20-4444001. Fax: 31-20-4442964. E-mail: s.stevens{at}azvu.nl.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|